FDA Highlights Programs for Innovators at ACR DSI Summit
The FDA joined the ACR®️ Data Science Summit June 9 to give an update about its Total Product Life Cycle Advisory Program.
Read moreACR Fellows Observed RUC Leaders
ACR® presented 23 Current Procedural Terminology® (CPT®) codes at the American Medical Association (AMA)/Specialty Society Relative Value Scale Update Committee (RUC) meeting, held Jan. 14–17 in Los Angeles.
These codes covered several radiology and multi specialty procedures, including:
ACR RUC Advisor Andrew Moriarity, MD, MBA, and ACR RUC Alternate Advisor Michael Booker, MD, MBA, presented practice expense and physician work recommendations for all five code families. Robert Bour, MD, RUC Advisor for the Radiological Society of North America, supported presentations on the MRA head and neck and CT upper extremity codes.
Looking ahead, ACR is preparing for the April 2026 RUC meeting in Chicago. The CPT survey cycle is expected to begin in February, and members are encouraged to complete any surveys they receive due to the short response window.
ACR also welcomed four guests who observed the RUC process:
Before the meeting, guests joined conference calls where they heard multi society discussions on strategy and preparation. During the meeting, they observed ACR’s RUC leadership team, along with advisors from other radiology specialty societies, gaining firsthand insight into the valuation and recommendation process.
For more information, contact Stephanie Le, ACR Director, Economic Policy.
FDA Highlights Programs for Innovators at ACR DSI Summit
The FDA joined the ACR®️ Data Science Summit June 9 to give an update about its Total Product Life Cycle Advisory Program.
Read moreLower Fee Now in Effect to File No Surprises Act Disputes
Federal agencies released a final rule that updates the No Surprises Act independent dispute resolution process. The rule lowers the IDR administrative or filing fee from $115 to $15.
Read moreACR Urges Funding for NIH All of Us Program
ACR urges Congress to provide dedicated funding for NIH’s All of Us Research Program, a leader in precision medicine technologies and a valuable tool for researchers.
Read more